FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Atropine Sulfate Ophthalmic Ointment
Status: Currently in Shortage
»Date first posted: 10/18/2019
»Therapeutic Categories: Ophthalmology

Bausch Health (Revised 12/13/2019)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1% (10 mg/g), 3.5 g tube (NDC 24208-825-55) Availability limited to product already in pharmacies until resumption of manufacturing in January 2020 and distribution in February 2020 Currently qualifying alternate supplier of inactive ingredient Shortage of an inactive ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English